Solidarity Wealth LLC Sells 2,712 Shares of UnitedHealth Group Incorporated $UNH

Solidarity Wealth LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 38.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,278 shares of the healthcare conglomerate’s stock after selling 2,712 shares during the quarter. Solidarity Wealth LLC’s holdings in UnitedHealth Group were worth $1,335,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of UNH. Caitlin John LLC lifted its holdings in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after buying an additional 111 shares in the last quarter. Murphy Pohlad Asset Management LLC raised its stake in shares of UnitedHealth Group by 21.8% during the second quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock valued at $1,380,000 after acquiring an additional 791 shares in the last quarter. Triumph Capital Management bought a new position in UnitedHealth Group in the second quarter worth approximately $1,324,000. Wealth Effects LLC increased its holdings in UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after purchasing an additional 591 shares during the period. Finally, Towercrest Capital Management purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth $236,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.0%

UnitedHealth Group stock opened at $329.75 on Monday. The business has a fifty day moving average price of $343.37 and a 200-day moving average price of $314.95. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $622.83. The stock has a market capitalization of $298.70 billion, a price-to-earnings ratio of 17.21, a PEG ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter last year, the company earned $7.15 earnings per share. The company’s quarterly revenue was up 12.2% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Analyst Ratings Changes

Several analysts recently weighed in on UNH shares. Barclays lifted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. JPMorgan Chase & Co. boosted their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. UBS Group increased their target price on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Finally, Piper Sandler decreased their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.